1. Home
  2. PGEN vs TLS Comparison

PGEN vs TLS Comparison

Compare PGEN & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$3.97

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Telos Corporation

TLS

Telos Corporation

HOLD

Current Price

$4.17

Market Cap

317.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
TLS
Founded
1998
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
317.1M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
PGEN
TLS
Price
$3.97
$4.17
Analyst Decision
Buy
Buy
Analyst Count
5
5
Target Price
$8.33
$7.90
AVG Volume (30 Days)
5.1M
901.4K
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
31.51
EPS
N/A
N/A
Revenue
$230,981,000.00
$164,805,000.00
Revenue This Year
$1,115.92
$18.72
Revenue Next Year
$81.04
$14.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
52.21
52 Week Low
$1.12
$1.83
52 Week High
$5.47
$8.36

Technical Indicators

Market Signals
Indicator
PGEN
TLS
Relative Strength Index (RSI) 54.48 45.21
Support Level $3.31 $3.88
Resistance Level $4.44 $4.69
Average True Range (ATR) 0.31 0.25
MACD 0.11 0.02
Stochastic Oscillator 74.09 45.93

Price Performance

Historical Comparison
PGEN
TLS

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

Share on Social Networks: